glp 1 and bowel movements Diarrhea on a GLP-1 is common, predictable, manageable. Here's what's driving it and what to do about it. #obesitymedicine #womenshealth #obesitydoctor​​​​​​​​​​​​​​​​ Clinical Recommendations to Manage Gastrointestinal

Eur J Cardiovasc Nurs (2006) 5:99101

Medication, nutrition, and exercise decisions should be individualized with an appropriate healthcare professional.

Clinical Evidence: Anxiety Risk on GLP-1 Receptor Agonists Major semaglutide trials, including STEP and SUSTAIN programs, reported anxiety in fewer than 3% of treatment participantsrates comparable to placebo control groups

Semaglutide (Ozempic, Rybelsus) is the most commonly prescribed

Semaglutide use and weight loss Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that Three brand names for semaglutide have been approved by the Food and Drug Administration (FDA) for different purposes: Wegovy: FDA-approved for weight loss and reducing the risk of cardiovascular disease

Genetic variants in pathways controlling appetite, glucose regulation, and metabolic rate (such as GLP1R rs6923761, GIPR rs1800437, and FTO rs9939609) may influence how a person's body responds to GLP-1 therapy